PRMT1 and neoplasm: Given that Myc overexpression occurs in ~40% of PDAC62 and that Myc-dependent tumors are particularly sensitive to protein synthesis inhibition63, we assessed whether pharmacologic inhibition of Prmt1 would impede tumor growth in vivo.